Novel motif:92
From FANTOM5_SSTAR
name: | motif92_GCGKWWNAA |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0019058 | viral infectious cycle | 2.188171e-16 |
GO:0071156 | regulation of cell cycle arrest | 1.129977e-14 |
GO:0000075 | cell cycle checkpoint | 3.326130e-13 |
GO:0022415 | viral reproductive process | 1.565818e-12 |
GO:0006414 | translational elongation | 1.755536e-12 |
GO:0019083 | viral transcription | 2.059186e-12 |
GO:0006415 | translational termination | 9.854023e-12 |
GO:0034623 | cellular macromolecular complex disassembly | 1.909819e-11 |
GO:0071845 | cellular component disassembly at cellular level | 2.828610e-11 |
GO:0022411 | cellular component disassembly | 7.994682e-11 |
GO:0032984 | macromolecular complex disassembly | 9.133804e-11 |
GO:0016032 | viral reproduction | 1.050183e-10 |
GO:0043624 | cellular protein complex disassembly | 1.750861e-10 |
GO:0030262 | apoptotic nuclear change | 5.568574e-10 |
GO:0043241 | protein complex disassembly | 9.325197e-10 |
GO:0000236 | mitotic prometaphase | 2.296125e-9 |
GO:0000088 | mitotic prophase | 4.259476e-9 |
GO:0006412 | translation | 8.154606e-9 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 1.211092e-8 |
GO:0016071 | mRNA metabolic process | 1.253234e-8 |
GO:0010498 | proteasomal protein catabolic process | 1.385914e-8 |
GO:0048280 | vesicle fusion with Golgi apparatus | 1.532698e-8 |
GO:0097039 | protein linear polyubiquitination | 2.017070e-8 |
GO:0007208 | activation of phospholipase C activity by serotonin receptor signaling pathway | 2.394444e-8 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 3.760990e-8 |
GO:0010564 | regulation of cell cycle process | 4.228090e-8 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.074410e-8 |
GO:0007093 | mitotic cell cycle checkpoint | 5.085028e-8 |
GO:0022403 | cell cycle phase | 5.177915e-8 |
GO:0071173 | spindle assembly checkpoint | 5.205839e-8 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 5.551587e-8 |
GO:0000278 | mitotic cell cycle | 6.550270e-8 |
GO:0021846 | cell proliferation in forebrain | 7.330348e-8 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 8.650745e-8 |
GO:0031577 | spindle checkpoint | 9.208132e-8 |
GO:0045906 | negative regulation of vasoconstriction | 1.367649e-7 |
GO:0000279 | M phase | 1.529193e-7 |
GO:0022027 | interkinetic nuclear migration | 1.549884e-7 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 1.702430e-7 |
GO:0048285 | organelle fission | 1.908396e-7 |
GO:2000659 | regulation of interleukin-1-mediated signaling pathway | 2.388695e-7 |
GO:0090304 | nucleic acid metabolic process | 2.483572e-7 |
GO:0000209 | protein polyubiquitination | 2.620196e-7 |
GO:0090281 | negative regulation of calcium ion import | 3.257041e-7 |
GO:0071584 | negative regulation of zinc ion import | 3.257041e-7 |
GO:0034660 | ncRNA metabolic process | 3.299663e-7 |
GO:0007067 | mitosis | 3.914136e-7 |
GO:0032581 | ER-dependent peroxisome organization | 4.240947e-7 |
GO:0006139 | nucleobase-containing compound metabolic process | 4.698343e-7 |
GO:0010506 | regulation of autophagy | 4.995173e-7 |
GO:0031167 | rRNA methylation | 5.318902e-7 |
GO:0045005 | maintenance of fidelity involved in DNA-dependent DNA replication | 6.955858e-7 |
GO:0035928 | rRNA import into mitochondrion | 6.959549e-7 |
GO:0042254 | ribosome biogenesis | 9.126449e-7 |
GO:0051351 | positive regulation of ligase activity | 1.039641e-6 |
GO:0000087 | M phase of mitotic cell cycle | 1.090721e-6 |
GO:0034766 | negative regulation of ion transmembrane transport | 1.133276e-6 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.190870e-6 |
GO:0045839 | negative regulation of mitosis | 1.221896e-6 |
GO:0010587 | miRNA catabolic process | 1.403697e-6 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.624583e-6 |
GO:0051647 | nucleus localization | 1.698575e-6 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 1.965080e-6 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 1.978067e-6 |
GO:0051029 | rRNA transport | 1.988893e-6 |
GO:0046796 | viral genome transport in host cell | 2.009909e-6 |
GO:0006611 | protein export from nucleus | 2.138495e-6 |
GO:0006396 | RNA processing | 2.538772e-6 |
GO:0000154 | rRNA modification | 2.544613e-6 |
GO:0031018 | endocrine pancreas development | 2.546581e-6 |
GO:0080009 | mRNA methylation | 2.613476e-6 |
GO:0042255 | ribosome assembly | 3.251503e-6 |
GO:0001510 | RNA methylation | 3.290727e-6 |
GO:0042396 | phosphagen biosynthetic process | 3.971843e-6 |
GO:0051340 | regulation of ligase activity | 4.582390e-6 |
GO:0071585 | detoxification of cadmium ion | 5.010060e-6 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 5.373093e-6 |
GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 5.525514e-6 |
GO:0071158 | positive regulation of cell cycle arrest | 6.030938e-6 |
GO:0010467 | gene expression | 6.270685e-6 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 6.525095e-6 |
GO:0033574 | response to testosterone stimulus | 7.637376e-6 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 7.706036e-6 |
GO:0070979 | protein K11-linked ubiquitination | 7.964025e-6 |
GO:0046479 | glycosphingolipid catabolic process | 8.640619e-6 |
GO:0031297 | replication fork processing | 1.030098e-5 |
GO:0051301 | cell division | 1.096540e-5 |
GO:0046314 | phosphocreatine biosynthetic process | 1.105328e-5 |
GO:0031398 | positive regulation of protein ubiquitination | 1.111935e-5 |
GO:0034728 | nucleosome organization | 1.152567e-5 |
GO:0006529 | asparagine biosynthetic process | 1.262170e-5 |
GO:0031570 | DNA integrity checkpoint | 1.336589e-5 |
GO:0035229 | positive regulation of glutamate-cysteine ligase activity | 1.456798e-5 |
GO:0000077 | DNA damage checkpoint | 1.763597e-5 |
GO:0006552 | leucine catabolic process | 1.791181e-5 |
GO:0044265 | cellular macromolecule catabolic process | 1.873461e-5 |
GO:0051974 | negative regulation of telomerase activity | 2.012923e-5 |
GO:0034641 | cellular nitrogen compound metabolic process | 2.121764e-5 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 2.122094e-5 |
GO:0000712 | resolution of meiotic recombination intermediates | 2.168060e-5 |
GO:0051444 | negative regulation of ubiquitin-protein ligase activity | 2.196926e-5 |
GO:0071539 | protein localization to centrosome | 2.259085e-5 |
GO:0007346 | regulation of mitotic cell cycle | 2.786225e-5 |
GO:0022402 | cell cycle process | 3.120399e-5 |
GO:0034453 | microtubule anchoring | 3.185071e-5 |
GO:0046477 | glycosylceramide catabolic process | 3.220593e-5 |
GO:0071843 | cellular component biogenesis at cellular level | 3.302640e-5 |
GO:0006458 | 'de novo' protein folding | 3.598477e-5 |
GO:0046950 | cellular ketone body metabolic process | 3.970687e-5 |
GO:0022613 | ribonucleoprotein complex biogenesis | 3.973772e-5 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.113440e-5 |
GO:0016073 | snRNA metabolic process | 4.308962e-5 |
GO:0051041 | positive regulation of calcium-independent cell-cell adhesion | 4.329904e-5 |
GO:0050902 | leukocyte adhesive activation | 4.329904e-5 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 4.357003e-5 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 4.406292e-5 |
GO:0006268 | DNA unwinding involved in replication | 4.414427e-5 |
GO:0006398 | histone mRNA 3'-end processing | 4.640288e-5 |
GO:0034470 | ncRNA processing | 4.973677e-5 |
GO:0031575 | mitotic cell cycle G1/S transition checkpoint | 5.134387e-5 |
GO:0032446 | protein modification by small protein conjugation | 5.195371e-5 |
GO:0032365 | intracellular lipid transport | 6.300011e-5 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 6.608485e-5 |
GO:0031427 | response to methotrexate | 6.785454e-5 |
GO:0016567 | protein ubiquitination | 6.972145e-5 |
GO:0008334 | histone mRNA metabolic process | 7.159845e-5 |
GO:0043550 | regulation of lipid kinase activity | 7.203897e-5 |
GO:0006333 | chromatin assembly or disassembly | 7.537957e-5 |
GO:0046951 | ketone body biosynthetic process | 7.743651e-5 |
GO:0030953 | astral microtubule organization | 7.917097e-5 |
GO:0031396 | regulation of protein ubiquitination | 7.925107e-5 |
GO:0034621 | cellular macromolecular complex subunit organization | 7.988224e-5 |
GO:0019941 | modification-dependent protein catabolic process | 8.021843e-5 |
GO:0006353 | transcription termination, DNA-dependent | 8.159446e-5 |
GO:0034661 | ncRNA catabolic process | 8.558906e-5 |
GO:0071779 | G1/S transition checkpoint | 9.003607e-5 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 9.118580e-5 |
GO:0034080 | CenH3-containing nucleosome assembly at centromere | 9.399666e-5 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 9.403836e-5 |
GO:0021933 | radial glia guided migration of cerebellar granule cell | 1.000842e-4 |
GO:0043632 | modification-dependent macromolecule catabolic process | 1.030244e-4 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.031918e-4 |
GO:0007196 | inhibition of adenylate cyclase activity by metabotropic glutamate receptor signaling pathway | 1.125469e-4 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 1.163578e-4 |
GO:0045665 | negative regulation of neuron differentiation | 1.177859e-4 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.224444e-4 |
GO:0008298 | intracellular mRNA localization | 1.249552e-4 |
GO:0070127 | tRNA aminoacylation for mitochondrial protein translation | 1.288796e-4 |
GO:0007100 | mitotic centrosome separation | 1.293594e-4 |
GO:0070145 | mitochondrial asparaginyl-tRNA aminoacylation | 1.293594e-4 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.363583e-4 |
GO:0016070 | RNA metabolic process | 1.379327e-4 |
GO:0006807 | nitrogen compound metabolic process | 1.385474e-4 |
GO:0051208 | sequestering of calcium ion | 1.448068e-4 |
GO:0044257 | cellular protein catabolic process | 1.459986e-4 |
GO:0043551 | regulation of phosphatidylinositol 3-kinase activity | 1.526022e-4 |
GO:0006545 | glycine biosynthetic process | 1.535644e-4 |
GO:0043405 | regulation of MAP kinase activity | 1.599034e-4 |
GO:0070059 | apoptosis in response to endoplasmic reticulum stress | 1.681844e-4 |
GO:0072404 | signal transduction involved in G1/S transition checkpoint | 1.760995e-4 |
GO:0043951 | negative regulation of cAMP-mediated signaling | 1.820563e-4 |
GO:0007210 | serotonin receptor signaling pathway | 1.880208e-4 |
GO:0006683 | galactosylceramide catabolic process | 1.905022e-4 |
GO:0042026 | protein refolding | 1.933007e-4 |
GO:0031571 | mitotic cell cycle G1/S transition DNA damage checkpoint | 1.941989e-4 |
GO:0032851 | positive regulation of Rab GTPase activity | 1.998012e-4 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 2.051213e-4 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 2.051213e-4 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 2.198469e-4 |
GO:0072395 | signal transduction involved in cell cycle checkpoint | 2.216322e-4 |
GO:0000089 | mitotic metaphase | 2.280926e-4 |
GO:0071569 | protein ufmylation | 2.293506e-4 |
GO:0051900 | regulation of mitochondrial depolarization | 2.338260e-4 |
GO:0000216 | M/G1 transition of mitotic cell cycle | 2.451522e-4 |
GO:0019377 | glycolipid catabolic process | 2.478872e-4 |
GO:0015074 | DNA integration | 2.512836e-4 |
GO:0031397 | negative regulation of protein ubiquitination | 2.579351e-4 |
GO:0042770 | signal transduction in response to DNA damage | 2.613063e-4 |
GO:0043406 | positive regulation of MAP kinase activity | 2.651334e-4 |
GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway | 2.687280e-4 |
GO:0046105 | thymidine biosynthetic process | 2.811801e-4 |
GO:0032232 | negative regulation of actin filament bundle assembly | 3.201466e-4 |
GO:0006677 | glycosylceramide metabolic process | 3.224222e-4 |
GO:0090218 | positive regulation of lipid kinase activity | 3.233686e-4 |
GO:0006260 | DNA replication | 3.256996e-4 |
GO:0042256 | mature ribosome assembly | 3.265500e-4 |
GO:0051865 | protein autoubiquitination | 3.400627e-4 |
GO:0031497 | chromatin assembly | 3.461317e-4 |
GO:0006551 | leucine metabolic process | 3.470317e-4 |
GO:0016072 | rRNA metabolic process | 3.762530e-4 |
GO:0071824 | protein-DNA complex subunit organization | 3.823163e-4 |
GO:0046929 | negative regulation of neurotransmitter secretion | 3.852250e-4 |
GO:0032964 | collagen biosynthetic process | 3.925308e-4 |
GO:0006189 | 'de novo' IMP biosynthetic process | 3.929704e-4 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 4.056848e-4 |
GO:0007088 | regulation of mitosis | 4.208485e-4 |
GO:0008608 | attachment of spindle microtubules to kinetochore | 4.286505e-4 |
GO:0031055 | chromatin remodeling at centromere | 4.410187e-4 |
GO:0061351 | neural precursor cell proliferation | 4.592332e-4 |
GO:0001839 | neural plate morphogenesis | 4.734503e-4 |
GO:0010592 | positive regulation of lamellipodium assembly | 4.791807e-4 |
GO:0090068 | positive regulation of cell cycle process | 4.824007e-4 |
GO:0007049 | cell cycle | 5.174418e-4 |
GO:0006334 | nucleosome assembly | 5.273432e-4 |
GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 5.291454e-4 |
GO:0000093 | mitotic telophase | 5.295338e-4 |
GO:0022617 | extracellular matrix disassembly | 5.405307e-4 |
GO:0015693 | magnesium ion transport | 5.405307e-4 |
GO:0022004 | midbrain-hindbrain boundary maturation during brain development | 5.420763e-4 |
GO:2000002 | negative regulation of DNA damage checkpoint | 5.420763e-4 |
GO:0021588 | cerebellum formation | 5.420763e-4 |
GO:0021551 | central nervous system morphogenesis | 5.420763e-4 |
GO:0009070 | serine family amino acid biosynthetic process | 5.455147e-4 |
GO:0006882 | cellular zinc ion homeostasis | 6.114135e-4 |
GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 6.400929e-4 |
GO:0051902 | negative regulation of mitochondrial depolarization | 6.615425e-4 |
GO:0045040 | protein import into mitochondrial outer membrane | 6.670486e-4 |
GO:0006086 | acetyl-CoA biosynthetic process from pyruvate | 6.738346e-4 |
GO:0007051 | spindle organization | 6.895308e-4 |
GO:0048103 | somatic stem cell division | 7.436786e-4 |
GO:0043271 | negative regulation of ion transport | 7.538367e-4 |
GO:0006853 | carnitine shuttle | 7.936351e-4 |
GO:0070543 | response to linoleic acid | 8.233449e-4 |
GO:0090007 | regulation of mitotic anaphase | 8.233449e-4 |
GO:0034696 | response to prostaglandin F stimulus | 8.233449e-4 |
GO:0031120 | snRNA pseudouridine synthesis | 8.233449e-4 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 8.644602e-4 |
GO:0043029 | T cell homeostasis | 8.789659e-4 |
GO:0046104 | thymidine metabolic process | 8.882684e-4 |
GO:0032912 | negative regulation of transforming growth factor beta2 production | 9.463575e-4 |
GO:0070925 | organelle assembly | 9.764671e-4 |
GO:0006661 | phosphatidylinositol biosynthetic process | 9.768779e-4 |
GO:0031122 | cytoplasmic microtubule organization | 9.777363e-4 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 1.033480e-3 |
GO:0048385 | regulation of retinoic acid receptor signaling pathway | 1.071250e-3 |
GO:0042398 | cellular modified amino acid biosynthetic process | 1.073803e-3 |
GO:0042273 | ribosomal large subunit biogenesis | 1.078439e-3 |
GO:0030219 | megakaryocyte differentiation | 1.078439e-3 |
GO:0006974 | response to DNA damage stimulus | 1.084800e-3 |
GO:0042989 | sequestering of actin monomers | 1.091918e-3 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 1.101725e-3 |
GO:0014041 | regulation of neuron maturation | 1.110223e-3 |
GO:0061101 | neuroendocrine cell differentiation | 1.111701e-3 |
GO:0035372 | protein localization to microtubule | 1.111701e-3 |
GO:0060263 | regulation of respiratory burst | 1.148932e-3 |
GO:0006261 | DNA-dependent DNA replication | 1.155035e-3 |
GO:0006600 | creatine metabolic process | 1.195694e-3 |
GO:0051583 | dopamine uptake | 1.298866e-3 |
GO:0000375 | RNA splicing, via transesterification reactions | 1.310621e-3 |
GO:0015761 | mannose transport | 1.364680e-3 |
GO:0006369 | termination of RNA polymerase II transcription | 1.372143e-3 |
GO:0006379 | mRNA cleavage | 1.373634e-3 |
GO:0006513 | protein monoubiquitination | 1.385501e-3 |
GO:0043128 | positive regulation of 1-phosphatidylinositol 4-kinase activity | 1.395355e-3 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 1.402750e-3 |
GO:0001843 | neural tube closure | 1.409598e-3 |
GO:0006110 | regulation of glycolysis | 1.419149e-3 |
GO:0019376 | galactolipid catabolic process | 1.432662e-3 |
GO:0032543 | mitochondrial translation | 1.438159e-3 |
GO:0071502 | cellular response to temperature stimulus | 1.509774e-3 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 1.541792e-3 |
GO:0007521 | muscle cell fate determination | 1.569744e-3 |
GO:0009057 | macromolecule catabolic process | 1.662123e-3 |
GO:0071279 | cellular response to cobalt ion | 1.666850e-3 |
GO:0010637 | negative regulation of mitochondrial fusion | 1.666850e-3 |
GO:0032074 | negative regulation of nuclease activity | 1.666850e-3 |
GO:0010834 | telomere maintenance via telomere shortening | 1.668964e-3 |
GO:0060606 | tube closure | 1.735013e-3 |
GO:0006188 | IMP biosynthetic process | 1.746419e-3 |
GO:0045204 | MAPK export from nucleus | 1.773787e-3 |
GO:0045209 | MAPK phosphatase export from nucleus, leptomycin B sensitive | 1.773787e-3 |
GO:0009794 | regulation of mitotic cell cycle, embryonic | 1.780673e-3 |
GO:0045792 | negative regulation of cell size | 1.793423e-3 |
GO:0048742 | regulation of skeletal muscle fiber development | 1.819459e-3 |
GO:0009069 | serine family amino acid metabolic process | 1.898508e-3 |
GO:0007127 | meiosis I | 1.922188e-3 |
GO:0085020 | protein K6-linked ubiquitination | 1.973363e-3 |
GO:0032066 | nucleolus to nucleoplasm transport | 1.981431e-3 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 2.010862e-3 |
GO:0016180 | snRNA processing | 2.060556e-3 |
GO:0060136 | embryonic process involved in female pregnancy | 2.082312e-3 |
GO:0014020 | primary neural tube formation | 2.086799e-3 |
GO:0038007 | netrin-activated signaling pathway | 2.167340e-3 |
GO:0070842 | aggresome assembly | 2.190444e-3 |
GO:0031054 | pre-miRNA processing | 2.228045e-3 |
GO:0051661 | maintenance of centrosome location | 2.255904e-3 |
GO:2000781 | positive regulation of double-strand break repair | 2.313127e-3 |
GO:0019068 | virion assembly | 2.313127e-3 |
GO:0030163 | protein catabolic process | 2.321667e-3 |
GO:0043375 | CD8-positive, alpha-beta T cell lineage commitment | 2.330305e-3 |
GO:0032848 | negative regulation of cellular pH reduction | 2.330305e-3 |
GO:0014042 | positive regulation of neuron maturation | 2.330305e-3 |
GO:0021747 | cochlear nucleus development | 2.330305e-3 |
GO:0006363 | termination of RNA polymerase I transcription | 2.332465e-3 |
GO:0051926 | negative regulation of calcium ion transport | 2.402379e-3 |
GO:0051131 | chaperone-mediated protein complex assembly | 2.402941e-3 |
GO:0021915 | neural tube development | 2.403793e-3 |
GO:0046514 | ceramide catabolic process | 2.471442e-3 |
GO:0071900 | regulation of protein serine/threonine kinase activity | 2.609889e-3 |
GO:0048246 | macrophage chemotaxis | 2.636799e-3 |
GO:0009106 | lipoate metabolic process | 2.736566e-3 |
GO:0009726 | detection of endogenous stimulus | 2.843238e-3 |
GO:0035307 | positive regulation of protein dephosphorylation | 2.843626e-3 |
GO:0046732 | active induction of host immune response by virus | 2.867535e-3 |
GO:0001776 | leukocyte homeostasis | 2.903535e-3 |
GO:0034501 | protein localization to kinetochore | 2.919403e-3 |
GO:0070936 | protein K48-linked ubiquitination | 2.965868e-3 |
GO:0061144 | alveolar secondary septum development | 2.973986e-3 |
GO:0046668 | regulation of retinal cell programmed cell death | 3.012741e-3 |
GO:0051324 | prophase | 3.026511e-3 |
GO:0010823 | negative regulation of mitochondrion organization | 3.043111e-3 |
GO:0019229 | regulation of vasoconstriction | 3.081652e-3 |
GO:0034115 | negative regulation of heterotypic cell-cell adhesion | 3.105170e-3 |
GO:0032730 | positive regulation of interleukin-1 alpha production | 3.186227e-3 |
GO:0060019 | radial glial cell differentiation | 3.194372e-3 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 3.240306e-3 |
GO:0060659 | nipple sheath formation | 3.389934e-3 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 3.389934e-3 |
GO:0060649 | mammary gland bud elongation | 3.389934e-3 |
GO:0009786 | regulation of asymmetric cell division | 3.498548e-3 |
GO:0008057 | eye pigment granule organization | 3.498548e-3 |
GO:0035306 | positive regulation of dephosphorylation | 3.516230e-3 |
GO:0046125 | pyrimidine deoxyribonucleoside metabolic process | 3.576717e-3 |
GO:0090272 | negative regulation of fibroblast growth factor production | 3.584937e-3 |
GO:0006808 | regulation of nitrogen utilization | 3.618366e-3 |
GO:0019388 | galactose catabolic process | 3.618366e-3 |
GO:0002260 | lymphocyte homeostasis | 3.653641e-3 |
GO:0010523 | negative regulation of calcium ion transport into cytosol | 3.677592e-3 |
GO:0010591 | regulation of lamellipodium assembly | 3.696934e-3 |
GO:0070534 | protein K63-linked ubiquitination | 3.831621e-3 |
GO:0006337 | nucleosome disassembly | 3.864035e-3 |
GO:2000725 | regulation of cardiac muscle cell differentiation | 3.914285e-3 |
GO:0051168 | nuclear export | 3.933425e-3 |
GO:0006681 | galactosylceramide metabolic process | 3.995111e-3 |
GO:0046730 | induction of host immune response by virus | 4.007458e-3 |
GO:0006085 | acetyl-CoA biosynthetic process | 4.013078e-3 |
GO:0009059 | macromolecule biosynthetic process | 4.050445e-3 |
GO:0001840 | neural plate development | 4.149591e-3 |
GO:0006325 | chromatin organization | 4.161501e-3 |
GO:0006259 | DNA metabolic process | 4.218995e-3 |
GO:0043496 | regulation of protein homodimerization activity | 4.239568e-3 |
GO:0071812 | positive regulation of fever generation by positive regulation of prostaglandin secretion | 4.303996e-3 |
GO:0071848 | positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling | 4.303996e-3 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 4.311676e-3 |
GO:0002052 | positive regulation of neuroblast proliferation | 4.315862e-3 |
GO:0072393 | microtubule anchoring at microtubule organizing center | 4.333889e-3 |
GO:0034112 | positive regulation of homotypic cell-cell adhesion | 4.440153e-3 |
GO:2000348 | regulation of CD40 signaling pathway | 4.459670e-3 |
GO:0055069 | zinc ion homeostasis | 4.459670e-3 |
GO:0051153 | regulation of striated muscle cell differentiation | 4.602112e-3 |
GO:0006360 | transcription from RNA polymerase I promoter | 4.654058e-3 |
GO:0046671 | negative regulation of retinal cell programmed cell death | 4.691021e-3 |
GO:0072385 | minus-end-directed organelle transport along microtubule | 4.694887e-3 |
GO:0042249 | establishment of planar polarity of embryonic epithelium | 4.825378e-3 |
GO:0006780 | uroporphyrinogen III biosynthetic process | 4.847229e-3 |
GO:0035519 | protein K29-linked ubiquitination | 4.866604e-3 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.866604e-3 |
GO:0001841 | neural tube formation | 4.873617e-3 |
GO:0051313 | attachment of spindle microtubules to chromosome | 4.883195e-3 |
GO:0003300 | cardiac muscle hypertrophy | 4.913959e-3 |
GO:0060045 | positive regulation of cardiac muscle cell proliferation | 5.034605e-3 |
GO:0030579 | ubiquitin-dependent SMAD protein catabolic process | 5.079082e-3 |
GO:0048002 | antigen processing and presentation of peptide antigen | 5.147669e-3 |
GO:0045769 | negative regulation of asymmetric cell division | 5.209147e-3 |
GO:0071277 | cellular response to calcium ion | 5.278631e-3 |
GO:0033326 | cerebrospinal fluid secretion | 5.392869e-3 |
GO:0007497 | posterior midgut development | 5.392869e-3 |
GO:0034436 | glycoprotein transport | 5.549314e-3 |
GO:0009720 | detection of hormone stimulus | 5.549314e-3 |
GO:0032741 | positive regulation of interleukin-18 production | 5.572074e-3 |
GO:0070371 | ERK1 and ERK2 cascade | 5.584113e-3 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 5.613068e-3 |
GO:0044314 | protein K27-linked ubiquitination | 5.827855e-3 |
GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway | 5.827855e-3 |
GO:0001988 | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 5.827855e-3 |
GO:0071635 | negative regulation of transforming growth factor beta production | 5.921046e-3 |
GO:0008612 | peptidyl-lysine modification to hypusine | 5.932556e-3 |
GO:0017145 | stem cell division | 5.950290e-3 |
GO:0001808 | negative regulation of type IV hypersensitivity | 6.026000e-3 |
GO:2000786 | positive regulation of autophagic vacuole assembly | 6.026000e-3 |
GO:0043486 | histone exchange | 6.027282e-3 |
GO:0006564 | L-serine biosynthetic process | 6.057901e-3 |
GO:0003254 | regulation of membrane depolarization | 6.286836e-3 |
GO:0000084 | S phase of mitotic cell cycle | 6.303145e-3 |
GO:0046605 | regulation of centrosome cycle | 6.393100e-3 |
GO:0021932 | hindbrain radial glia guided cell migration | 6.459782e-3 |
GO:0010508 | positive regulation of autophagy | 6.459782e-3 |
GO:0046521 | sphingoid catabolic process | 6.522673e-3 |
GO:0021873 | forebrain neuroblast division | 6.554454e-3 |
GO:0006298 | mismatch repair | 6.717425e-3 |
GO:0071374 | cellular response to parathyroid hormone stimulus | 6.781059e-3 |
GO:0006281 | DNA repair | 6.809423e-3 |
GO:0007216 | metabotropic glutamate receptor signaling pathway | 6.867874e-3 |
GO:0034349 | glial cell apoptosis | 6.867874e-3 |
GO:0044260 | cellular macromolecule metabolic process | 6.884497e-3 |
GO:0060025 | regulation of synaptic activity | 6.910149e-3 |
GO:0006338 | chromatin remodeling | 6.987967e-3 |
GO:0051466 | positive regulation of corticotropin-releasing hormone secretion | 7.120470e-3 |
GO:0045618 | positive regulation of keratinocyte differentiation | 7.120798e-3 |
GO:2000727 | positive regulation of cardiac muscle cell differentiation | 7.126714e-3 |
GO:2000987 | positive regulation of behavioral fear response | 7.126714e-3 |
GO:0003185 | sinoatrial valve morphogenesis | 7.126714e-3 |
GO:0035984 | cellular response to trichostatin A | 7.126714e-3 |
GO:0003138 | primary heart field specification | 7.126714e-3 |
GO:0021903 | rostrocaudal neural tube patterning | 7.142464e-3 |
GO:0016574 | histone ubiquitination | 7.158492e-3 |
GO:0046604 | positive regulation of mitotic centrosome separation | 7.209320e-3 |
GO:0007161 | calcium-independent cell-matrix adhesion | 7.209320e-3 |
GO:0007057 | spindle assembly involved in female meiosis I | 7.209320e-3 |
GO:0000188 | inactivation of MAPK activity | 7.273527e-3 |
GO:0060430 | lung saccule development | 7.342069e-3 |
GO:0051320 | S phase | 7.364830e-3 |
GO:0034635 | glutathione transport | 7.380857e-3 |
GO:0001807 | regulation of type IV hypersensitivity | 7.380857e-3 |
GO:0009107 | lipoate biosynthetic process | 7.380857e-3 |
GO:0051782 | negative regulation of cell division | 7.396359e-3 |
GO:0060282 | positive regulation of oocyte development | 7.712360e-3 |
GO:0010625 | positive regulation of Schwann cell proliferation | 7.712360e-3 |
GO:0045132 | meiotic chromosome segregation | 7.772550e-3 |
GO:0048247 | lymphocyte chemotaxis | 7.840571e-3 |
GO:0060061 | Spemann organizer formation | 7.881991e-3 |
GO:0048671 | negative regulation of collateral sprouting | 7.884170e-3 |
GO:0006435 | threonyl-tRNA aminoacylation | 8.172675e-3 |
GO:0060534 | trachea cartilage development | 8.333951e-3 |
GO:0045606 | positive regulation of epidermal cell differentiation | 8.333951e-3 |
GO:0043506 | regulation of JUN kinase activity | 8.339496e-3 |
GO:0065004 | protein-DNA complex assembly | 8.396179e-3 |
GO:0045986 | negative regulation of smooth muscle contraction | 8.480091e-3 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 8.480091e-3 |
GO:0009817 | defense response to fungus, incompatible interaction | 8.480091e-3 |
GO:0051972 | regulation of telomerase activity | 8.543132e-3 |
GO:0043044 | ATP-dependent chromatin remodeling | 8.639617e-3 |
GO:0001955 | blood vessel maturation | 8.691131e-3 |
GO:0045793 | positive regulation of cell size | 8.835325e-3 |
GO:0006007 | glucose catabolic process | 8.897417e-3 |
GO:0032214 | negative regulation of telomere maintenance via semi-conservative replication | 8.921880e-3 |
GO:0001309 | age-dependent telomere shortening | 8.921880e-3 |
GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 8.989975e-3 |
GO:0046952 | ketone body catabolic process | 8.989975e-3 |
GO:0010700 | negative regulation of norepinephrine secretion | 8.992837e-3 |
GO:0060489 | planar dichotomous subdivision of terminal units involved in lung branching morphogenesis | 9.076804e-3 |
GO:0060490 | lateral sprouting involved in lung morphogenesis | 9.076804e-3 |
GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis | 9.076804e-3 |
GO:0002051 | osteoblast fate commitment | 9.076804e-3 |
GO:0009440 | cyanate catabolic process | 9.076804e-3 |
GO:0048105 | establishment of body hair planar orientation | 9.076804e-3 |
GO:0071902 | positive regulation of protein serine/threonine kinase activity | 9.148127e-3 |
GO:0016568 | chromatin modification | 9.149678e-3 |
GO:0002439 | chronic inflammatory response to antigenic stimulus | 9.302796e-3 |
GO:0034645 | cellular macromolecule biosynthetic process | 9.379312e-3 |
GO:0032367 | intracellular cholesterol transport | 9.534579e-3 |
GO:0070159 | mitochondrial threonyl-tRNA aminoacylation | 9.604060e-3 |
GO:0045661 | regulation of myoblast differentiation | 9.858547e-3 |
GO:0007285 | primary spermatocyte growth | 1.009253e-2 |
GO:0001731 | formation of translation preinitiation complex | 1.009253e-2 |
GO:0006403 | RNA localization | 1.009437e-2 |
GO:0010948 | negative regulation of cell cycle process | 1.022296e-2 |
GO:0000090 | mitotic anaphase | 1.022730e-2 |
GO:0051497 | negative regulation of stress fiber assembly | 1.027147e-2 |
GO:0051409 | response to nitrosative stress | 1.028516e-2 |
GO:0003333 | amino acid transmembrane transport | 1.034719e-2 |
GO:0051329 | interphase of mitotic cell cycle | 1.034835e-2 |
GO:0051169 | nuclear transport | 1.041660e-2 |
GO:0019374 | galactolipid metabolic process | 1.042094e-2 |
GO:0051640 | organelle localization | 1.054809e-2 |
GO:0034498 | early endosome to Golgi transport | 1.065837e-2 |
GO:0090075 | relaxation of muscle | 1.070794e-2 |
GO:0043949 | regulation of cAMP-mediated signaling | 1.070794e-2 |
GO:0045343 | regulation of MHC class I biosynthetic process | 1.078377e-2 |
GO:0031536 | positive regulation of exit from mitosis | 1.078659e-2 |
GO:0006839 | mitochondrial transport | 1.081284e-2 |
GO:0008652 | cellular amino acid biosynthetic process | 1.101820e-2 |
GO:0006364 | rRNA processing | 1.114539e-2 |
GO:0010799 | regulation of peptidyl-threonine phosphorylation | 1.121747e-2 |
GO:0048743 | positive regulation of skeletal muscle fiber development | 1.136345e-2 |
GO:0060364 | frontal suture morphogenesis | 1.164011e-2 |
GO:0001958 | endochondral ossification | 1.172486e-2 |
GO:0032740 | positive regulation of interleukin-17 production | 1.175427e-2 |
GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport | 1.182909e-2 |
GO:0060112 | generation of ovulation cycle rhythm | 1.182909e-2 |
GO:0016241 | regulation of macroautophagy | 1.182909e-2 |
GO:0043471 | regulation of cellular carbohydrate catabolic process | 1.216368e-2 |
GO:0010826 | negative regulation of centrosome duplication | 1.240749e-2 |
GO:0035645 | enteric smooth muscle cell differentiation | 1.241507e-2 |
GO:0071228 | cellular response to tumor cell | 1.259882e-2 |
GO:0090251 | protein localization involved in establishment of planar polarity | 1.259882e-2 |
GO:0019402 | galactitol metabolic process | 1.259882e-2 |
GO:0044088 | regulation of vacuole organization | 1.259882e-2 |
GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus | 1.259882e-2 |
GO:0006096 | glycolysis | 1.279552e-2 |
GO:0007522 | visceral muscle development | 1.283681e-2 |
GO:0003310 | pancreatic A cell differentiation | 1.288323e-2 |
GO:0060648 | mammary gland bud morphogenesis | 1.289399e-2 |
GO:0045907 | positive regulation of vasoconstriction | 1.301189e-2 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 1.316761e-2 |
GO:0001782 | B cell homeostasis | 1.332276e-2 |
GO:0045663 | positive regulation of myoblast differentiation | 1.334225e-2 |
GO:0014065 | phosphatidylinositol 3-kinase cascade | 1.338208e-2 |
GO:0051325 | interphase | 1.338969e-2 |
GO:0090009 | primitive streak formation | 1.354388e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0016139 | glycoside catabolic process | 5.636723e-10 |
GO:0042069 | regulation of catecholamine metabolic process | 1.188270e-9 |
GO:0042053 | regulation of dopamine metabolic process | 2.063665e-9 |
GO:0060659 | nipple sheath formation | 3.328922e-9 |
GO:0060649 | mammary gland bud elongation | 3.328922e-9 |
GO:0033238 | regulation of cellular amine metabolic process | 8.165563e-9 |
GO:0009992 | cellular water homeostasis | 1.517956e-8 |
GO:0032872 | regulation of stress-activated MAPK cascade | 2.500505e-8 |
GO:0042424 | catecholamine catabolic process | 3.702186e-8 |
GO:0070831 | basement membrane assembly | 4.395899e-8 |
GO:0050668 | positive regulation of homocysteine metabolic process | 9.039334e-8 |
GO:0045963 | negative regulation of dopamine metabolic process | 9.039334e-8 |
GO:0071286 | cellular response to magnesium ion | 9.651755e-8 |
GO:0016137 | glycoside metabolic process | 1.910529e-7 |
GO:0016142 | O-glycoside catabolic process | 1.978288e-7 |
GO:0072355 | histone H3-T3 phosphorylation | 2.332687e-7 |
GO:0033240 | positive regulation of cellular amine metabolic process | 3.673654e-7 |
GO:0008334 | histone mRNA metabolic process | 3.791978e-7 |
GO:0000305 | response to oxygen radical | 3.853878e-7 |
GO:0042420 | dopamine catabolic process | 5.028711e-7 |
GO:0060658 | nipple morphogenesis | 5.975538e-7 |
GO:0015876 | acetyl-CoA transport | 6.725010e-7 |
GO:0061136 | regulation of proteasomal protein catabolic process | 6.782918e-7 |
GO:0060264 | regulation of respiratory burst involved in inflammatory response | 9.946081e-7 |
GO:0019285 | glycine betaine biosynthetic process from choline | 9.946081e-7 |
GO:0021568 | rhombomere 2 development | 9.946081e-7 |
GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development | 1.197730e-6 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.540234e-6 |
GO:0007064 | mitotic sister chromatid cohesion | 1.873671e-6 |
GO:0030038 | contractile actin filament bundle assembly | 1.912954e-6 |
GO:0035912 | dorsal aorta morphogenesis | 1.912954e-6 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 2.853742e-6 |
GO:0071044 | histone mRNA catabolic process | 2.889785e-6 |
GO:0007059 | chromosome segregation | 3.397670e-6 |
GO:0016140 | O-glycoside metabolic process | 3.844799e-6 |
GO:0090398 | cellular senescence | 4.040307e-6 |
GO:0048680 | positive regulation of axon regeneration | 4.503209e-6 |
GO:0072079 | nephron tubule formation | 5.067329e-6 |
GO:0008652 | cellular amino acid biosynthetic process | 5.761632e-6 |
GO:0031331 | positive regulation of cellular catabolic process | 5.995410e-6 |
GO:0042428 | serotonin metabolic process | 6.286362e-6 |
GO:0090399 | replicative senescence | 6.617400e-6 |
GO:0045764 | positive regulation of cellular amino acid metabolic process | 6.900397e-6 |
GO:0060648 | mammary gland bud morphogenesis | 6.900397e-6 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 6.900397e-6 |
GO:0046477 | glycosylceramide catabolic process | 7.310216e-6 |
GO:0042417 | dopamine metabolic process | 8.020702e-6 |
GO:0033314 | mitotic cell cycle DNA replication checkpoint | 9.864016e-6 |
GO:0048285 | organelle fission | 1.020272e-5 |
GO:0007569 | cell aging | 1.400976e-5 |
GO:0030104 | water homeostasis | 1.570020e-5 |
GO:0060045 | positive regulation of cardiac muscle cell proliferation | 1.631256e-5 |
GO:0060263 | regulation of respiratory burst | 1.702242e-5 |
GO:0000413 | protein peptidyl-prolyl isomerization | 1.756890e-5 |
GO:0051340 | regulation of ligase activity | 1.756890e-5 |
GO:0060266 | negative regulation of respiratory burst involved in inflammatory response | 1.882697e-5 |
GO:0051451 | myoblast migration | 1.905009e-5 |
GO:0051176 | positive regulation of sulfur metabolic process | 1.905009e-5 |
GO:0048291 | isotype switching to IgG isotypes | 2.089362e-5 |
GO:0002368 | B cell cytokine production | 2.089362e-5 |
GO:0072513 | positive regulation of secondary heart field cardioblast proliferation | 2.315154e-5 |
GO:0006102 | isocitrate metabolic process | 2.315154e-5 |
GO:0090231 | regulation of spindle checkpoint | 2.451468e-5 |
GO:0031570 | DNA integrity checkpoint | 2.514272e-5 |
GO:0071248 | cellular response to metal ion | 2.632965e-5 |
GO:0021930 | cerebellar granule cell precursor proliferation | 2.712389e-5 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.748918e-5 |
GO:0072086 | specification of loop of Henle identity | 2.748918e-5 |
GO:0070303 | negative regulation of stress-activated protein kinase signaling cascade | 2.753297e-5 |
GO:0071711 | basement membrane organization | 2.854965e-5 |
GO:0000070 | mitotic sister chromatid segregation | 2.883786e-5 |
GO:0007067 | mitosis | 3.004348e-5 |
GO:0061333 | renal tubule morphogenesis | 3.215050e-5 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 3.377805e-5 |
GO:0043149 | stress fiber assembly | 3.490565e-5 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 3.490565e-5 |
GO:0001947 | heart looping | 3.835436e-5 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 3.983810e-5 |
GO:0060347 | heart trabecula formation | 4.584388e-5 |
GO:0007379 | segment specification | 4.591130e-5 |
GO:0072199 | regulation of mesenchymal cell proliferation involved in ureter development | 4.671223e-5 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 4.857050e-5 |
GO:0000087 | M phase of mitotic cell cycle | 5.249764e-5 |
GO:0010735 | positive regulation of transcription via serum response element binding | 5.275826e-5 |
GO:0000077 | DNA damage checkpoint | 5.276762e-5 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 5.851532e-5 |
GO:0070830 | tight junction assembly | 6.371134e-5 |
GO:0018208 | peptidyl-proline modification | 6.888647e-5 |
GO:0072592 | oxygen metabolic process | 7.215522e-5 |
GO:0006578 | betaine biosynthetic process | 7.463743e-5 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 7.464544e-5 |
GO:0006974 | response to DNA damage stimulus | 8.366501e-5 |
GO:0000819 | sister chromatid segregation | 8.511648e-5 |
GO:0019430 | removal of superoxide radicals | 8.983658e-5 |
GO:0033561 | regulation of water loss via skin | 9.544912e-5 |
GO:0032312 | regulation of ARF GTPase activity | 9.560330e-5 |
GO:0042772 | DNA damage response, signal transduction resulting in transcription | 1.036576e-4 |
GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity | 1.040433e-4 |
GO:0061351 | neural precursor cell proliferation | 1.124674e-4 |
GO:0042218 | 1-aminocyclopropane-1-carboxylate biosynthetic process | 1.170566e-4 |
GO:0006710 | androgen catabolic process | 1.195731e-4 |
GO:0090073 | positive regulation of protein homodimerization activity | 1.247186e-4 |
GO:0032874 | positive regulation of stress-activated MAPK cascade | 1.247186e-4 |
GO:0031572 | G2/M transition DNA damage checkpoint | 1.258322e-4 |
GO:2000781 | positive regulation of double-strand break repair | 1.358003e-4 |
GO:0060816 | random inactivation of X chromosome | 1.358003e-4 |
GO:0006666 | 3-keto-sphinganine metabolic process | 1.358003e-4 |
GO:0006409 | tRNA export from nucleus | 1.358003e-4 |
GO:0072081 | specification of nephron tubule identity | 1.403771e-4 |
GO:0043950 | positive regulation of cAMP-mediated signaling | 1.461824e-4 |
GO:0019370 | leukotriene biosynthetic process | 1.540502e-4 |
GO:0031440 | regulation of mRNA 3'-end processing | 1.587109e-4 |
GO:0043508 | negative regulation of JUN kinase activity | 1.587109e-4 |
GO:0051145 | smooth muscle cell differentiation | 1.756466e-4 |
GO:0071287 | cellular response to manganese ion | 1.864877e-4 |
GO:0032057 | negative regulation of translational initiation in response to stress | 1.869810e-4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.869972e-4 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.920580e-4 |
GO:0042398 | cellular modified amino acid biosynthetic process | 1.984956e-4 |
GO:0009309 | amine biosynthetic process | 1.994354e-4 |
GO:0006189 | 'de novo' IMP biosynthetic process | 2.007634e-4 |
GO:0001975 | response to amphetamine | 2.022188e-4 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 2.026150e-4 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.084210e-4 |
GO:0001964 | startle response | 2.326787e-4 |
GO:0043496 | regulation of protein homodimerization activity | 2.445737e-4 |
GO:0019858 | cytosine metabolic process | 2.617365e-4 |
GO:0006449 | regulation of translational termination | 2.639386e-4 |
GO:0045652 | regulation of megakaryocyte differentiation | 2.641050e-4 |
GO:0048143 | astrocyte activation | 2.679232e-4 |
GO:0071474 | cellular hyperosmotic response | 2.702192e-4 |
GO:0002352 | B cell negative selection | 2.702192e-4 |
GO:0042135 | neurotransmitter catabolic process | 2.785786e-4 |
GO:0015732 | prostaglandin transport | 2.799072e-4 |
GO:0060012 | synaptic transmission, glycinergic | 2.799072e-4 |
GO:0035886 | vascular smooth muscle cell differentiation | 2.878710e-4 |
GO:0006691 | leukotriene metabolic process | 2.924812e-4 |
GO:0048854 | brain morphogenesis | 2.965815e-4 |
GO:0000303 | response to superoxide | 2.986894e-4 |
GO:0046394 | carboxylic acid biosynthetic process | 3.038094e-4 |
GO:0032012 | regulation of ARF protein signal transduction | 3.053992e-4 |
GO:0007093 | mitotic cell cycle checkpoint | 3.053992e-4 |
GO:0046329 | negative regulation of JNK cascade | 3.072868e-4 |
GO:0060081 | membrane hyperpolarization | 3.072868e-4 |
GO:0072107 | positive regulation of ureteric bud formation | 3.141159e-4 |
GO:0060359 | response to ammonium ion | 3.236436e-4 |
GO:0030050 | vesicle transport along actin filament | 3.236436e-4 |
GO:0071158 | positive regulation of cell cycle arrest | 3.293454e-4 |
GO:0019087 | transformation of host cell by virus | 3.307472e-4 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 3.307472e-4 |
GO:0044241 | lipid digestion | 3.365804e-4 |
GO:0043032 | positive regulation of macrophage activation | 3.558667e-4 |
GO:0000076 | DNA replication checkpoint | 3.572226e-4 |
GO:0007057 | spindle assembly involved in female meiosis I | 3.672384e-4 |
GO:0072078 | nephron tubule morphogenesis | 3.704615e-4 |
GO:0071156 | regulation of cell cycle arrest | 3.794885e-4 |
GO:0030220 | platelet formation | 3.858510e-4 |
GO:0060075 | regulation of resting membrane potential | 3.909348e-4 |
GO:0060409 | positive regulation of acetylcholine metabolic process | 4.040702e-4 |
GO:0002541 | activation of plasma proteins involved in acute inflammatory response | 4.040702e-4 |
GO:2000111 | positive regulation of macrophage apoptosis | 4.084082e-4 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 4.084082e-4 |
GO:0045081 | negative regulation of interleukin-10 biosynthetic process | 4.104499e-4 |
GO:0007256 | activation of JNKK activity | 4.283998e-4 |
GO:0006982 | response to lipid hydroperoxide | 4.556228e-4 |
GO:0000089 | mitotic metaphase | 4.646806e-4 |
GO:0055021 | regulation of cardiac muscle tissue growth | 4.771626e-4 |
GO:0090009 | primitive streak formation | 5.076053e-4 |
GO:0006289 | nucleotide-excision repair | 5.090318e-4 |
GO:0000279 | M phase | 5.145806e-4 |
GO:0006586 | indolalkylamine metabolic process | 5.441864e-4 |
GO:0051351 | positive regulation of ligase activity | 5.441864e-4 |
GO:0061180 | mammary gland epithelium development | 5.760795e-4 |
GO:0043297 | apical junction assembly | 5.836245e-4 |
GO:0061014 | positive regulation of mRNA catabolic process | 5.929412e-4 |
GO:0042176 | regulation of protein catabolic process | 6.055919e-4 |
GO:0072268 | pattern specification involved in metanephros development | 6.155729e-4 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 6.155729e-4 |
GO:0072080 | nephron tubule development | 6.317048e-4 |
GO:0006584 | catecholamine metabolic process | 6.570605e-4 |
GO:0061004 | pattern specification involved in kidney development | 6.583790e-4 |
GO:0061384 | heart trabecular morphogenesis | 6.635723e-4 |
GO:0044283 | small molecule biosynthetic process | 6.739440e-4 |
GO:0048645 | organ formation | 6.834707e-4 |
GO:0009896 | positive regulation of catabolic process | 6.875365e-4 |
GO:0072172 | mesonephric tubule formation | 6.982037e-4 |
GO:0071879 | positive regulation of adrenergic receptor signaling pathway | 7.293443e-4 |
GO:0050717 | positive regulation of interleukin-1 alpha secretion | 7.293443e-4 |
GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development | 7.293443e-4 |
GO:0051602 | response to electrical stimulus | 7.476280e-4 |
GO:0048050 | post-embryonic eye morphogenesis | 7.612262e-4 |
GO:0009083 | branched chain family amino acid catabolic process | 7.699782e-4 |
GO:0048538 | thymus development | 7.993622e-4 |
GO:0072095 | regulation of branch elongation involved in ureteric bud branching | 8.083032e-4 |
GO:0014002 | astrocyte development | 8.528670e-4 |
GO:0042443 | phenylethylamine metabolic process | 8.867556e-4 |
GO:0051793 | medium-chain fatty acid catabolic process | 8.867556e-4 |
GO:0060025 | regulation of synaptic activity | 8.905641e-4 |
GO:2000987 | positive regulation of behavioral fear response | 8.905641e-4 |
GO:0035984 | cellular response to trichostatin A | 8.905641e-4 |
GO:0003185 | sinoatrial valve morphogenesis | 8.905641e-4 |
GO:0003138 | primary heart field specification | 8.905641e-4 |
GO:0007030 | Golgi organization | 9.095025e-4 |
GO:0045905 | positive regulation of translational termination | 9.421802e-4 |
GO:0006452 | translational frameshifting | 9.421802e-4 |
GO:0045901 | positive regulation of translational elongation | 9.421802e-4 |
GO:0021761 | limbic system development | 9.731978e-4 |
GO:0021782 | glial cell development | 9.859667e-4 |
GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 1.009393e-3 |
GO:0016567 | protein ubiquitination | 1.011673e-3 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 1.013904e-3 |
GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process | 1.014700e-3 |
GO:0031576 | G2/M transition checkpoint | 1.027017e-3 |
GO:0006463 | steroid hormone receptor complex assembly | 1.033621e-3 |
GO:0007096 | regulation of exit from mitosis | 1.053837e-3 |
GO:0000075 | cell cycle checkpoint | 1.101811e-3 |
GO:0006235 | dTTP biosynthetic process | 1.104691e-3 |
GO:0044088 | regulation of vacuole organization | 1.104691e-3 |
GO:0042744 | hydrogen peroxide catabolic process | 1.115256e-3 |
GO:0051276 | chromosome organization | 1.124609e-3 |
GO:0003207 | cardiac chamber formation | 1.151783e-3 |
GO:0051643 | endoplasmic reticulum localization | 1.164884e-3 |
GO:0048597 | post-embryonic camera-type eye morphogenesis | 1.164884e-3 |
GO:0071241 | cellular response to inorganic substance | 1.178504e-3 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.192182e-3 |
GO:0006734 | NADH metabolic process | 1.208322e-3 |
GO:0061326 | renal tubule development | 1.248920e-3 |
GO:0010922 | positive regulation of phosphatase activity | 1.280890e-3 |
GO:0006414 | translational elongation | 1.281665e-3 |
GO:0009147 | pyrimidine nucleoside triphosphate metabolic process | 1.307283e-3 |
GO:0048701 | embryonic cranial skeleton morphogenesis | 1.320292e-3 |
GO:0034498 | early endosome to Golgi transport | 1.342828e-3 |
GO:0055090 | acylglycerol homeostasis | 1.356456e-3 |
GO:0045019 | negative regulation of nitric oxide biosynthetic process | 1.378756e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 1.439076e-3 |
GO:0003179 | heart valve morphogenesis | 1.523143e-3 |
GO:0071374 | cellular response to parathyroid hormone stimulus | 1.523491e-3 |
GO:0006281 | DNA repair | 1.540093e-3 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 1.556616e-3 |
GO:0014898 | cardiac muscle hypertrophy in response to stress | 1.566904e-3 |
GO:0002309 | T cell proliferation involved in immune response | 1.582610e-3 |
GO:0034470 | ncRNA processing | 1.588964e-3 |
GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway | 1.597250e-3 |
GO:0003211 | cardiac ventricle formation | 1.637639e-3 |
GO:0046491 | L-methylmalonyl-CoA metabolic process | 1.713114e-3 |
GO:0001879 | detection of yeast | 1.713114e-3 |
GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway | 1.723516e-3 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 1.728816e-3 |
GO:0030431 | sleep | 1.784544e-3 |
GO:0048708 | astrocyte differentiation | 1.787056e-3 |
GO:0014050 | negative regulation of glutamate secretion | 1.809596e-3 |
GO:2000109 | regulation of macrophage apoptosis | 1.846906e-3 |
GO:0010042 | response to manganese ion | 1.866679e-3 |
GO:0016572 | histone phosphorylation | 1.918396e-3 |
GO:0034626 | fatty acid elongation, polyunsaturated fatty acid | 1.933467e-3 |
GO:0021546 | rhombomere development | 1.933467e-3 |
GO:0018027 | peptidyl-lysine dimethylation | 1.937706e-3 |
GO:0002227 | innate immune response in mucosa | 1.937706e-3 |
GO:0048679 | regulation of axon regeneration | 1.990737e-3 |
GO:0034644 | cellular response to UV | 2.005718e-3 |
GO:0010092 | specification of organ identity | 2.059114e-3 |
GO:0071459 | protein localization to chromosome, centromeric region | 2.078333e-3 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 2.078333e-3 |
GO:0060847 | endothelial cell fate specification | 2.083294e-3 |
GO:0046328 | regulation of JNK cascade | 2.133819e-3 |
GO:0046856 | phosphatidylinositol dephosphorylation | 2.141064e-3 |
GO:0006577 | betaine metabolic process | 2.154709e-3 |
GO:0034766 | negative regulation of ion transmembrane transport | 2.177671e-3 |
GO:0060572 | morphogenesis of an epithelial bud | 2.207760e-3 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 2.224037e-3 |
GO:0001777 | T cell homeostatic proliferation | 2.224037e-3 |
GO:0016574 | histone ubiquitination | 2.227449e-3 |
GO:0003170 | heart valve development | 2.336696e-3 |
GO:0035855 | megakaryocyte development | 2.340162e-3 |
GO:0051131 | chaperone-mediated protein complex assembly | 2.355716e-3 |
GO:0009048 | dosage compensation, by inactivation of X chromosome | 2.355716e-3 |
GO:0007049 | cell cycle | 2.383045e-3 |
GO:0045862 | positive regulation of proteolysis | 2.429904e-3 |
GO:0045885 | positive regulation of survival gene product expression | 2.439049e-3 |
GO:0060068 | vagina development | 2.551284e-3 |
GO:0043030 | regulation of macrophage activation | 2.554434e-3 |
GO:0035050 | embryonic heart tube development | 2.575612e-3 |
GO:0060603 | mammary gland duct morphogenesis | 2.585185e-3 |
GO:0008635 | activation of caspase activity by cytochrome c | 2.619553e-3 |
GO:0006396 | RNA processing | 2.638083e-3 |
GO:0072193 | ureter smooth muscle cell differentiation | 2.647490e-3 |
GO:0010458 | exit from mitosis | 2.647490e-3 |
GO:0010467 | gene expression | 2.688728e-3 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 2.702314e-3 |
GO:0032912 | negative regulation of transforming growth factor beta2 production | 2.716913e-3 |
GO:0045665 | negative regulation of neuron differentiation | 2.762057e-3 |
GO:0002042 | cell migration involved in sprouting angiogenesis | 2.840482e-3 |
GO:0010826 | negative regulation of centrosome duplication | 2.896099e-3 |
GO:0035750 | protein localization to myelin sheath abaxonal region | 2.896099e-3 |
GO:0000115 | regulation of transcription involved in S phase of mitotic cell cycle | 2.896099e-3 |
GO:0042133 | neurotransmitter metabolic process | 2.922834e-3 |
GO:0051182 | coenzyme transport | 2.934129e-3 |
GO:0006188 | IMP biosynthetic process | 2.934129e-3 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 2.996606e-3 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 3.001689e-3 |
GO:0046668 | regulation of retinal cell programmed cell death | 3.004324e-3 |
GO:0060292 | long term synaptic depression | 3.076280e-3 |
GO:0090068 | positive regulation of cell cycle process | 3.132433e-3 |
GO:0060420 | regulation of heart growth | 3.219695e-3 |
GO:0002076 | osteoblast development | 3.308670e-3 |
GO:0021986 | habenula development | 3.337657e-3 |
GO:0006680 | glucosylceramide catabolic process | 3.337657e-3 |
GO:0055024 | regulation of cardiac muscle tissue development | 3.350311e-3 |
GO:0006448 | regulation of translational elongation | 3.356015e-3 |
GO:0031396 | regulation of protein ubiquitination | 3.370264e-3 |
GO:0008033 | tRNA processing | 3.401935e-3 |
GO:0060948 | cardiac vascular smooth muscle cell development | 3.449364e-3 |
GO:0006265 | DNA topological change | 3.565175e-3 |
GO:0080135 | regulation of cellular response to stress | 3.601351e-3 |
GO:0072164 | mesonephric tubule development | 3.605840e-3 |
GO:0048703 | embryonic viscerocranium morphogenesis | 3.622588e-3 |
GO:0034442 | regulation of lipoprotein oxidation | 3.687810e-3 |
GO:0035058 | nonmotile primary cilium assembly | 3.743712e-3 |
GO:0045599 | negative regulation of fat cell differentiation | 3.754984e-3 |
GO:0035404 | histone-serine phosphorylation | 3.761271e-3 |
GO:0007043 | cell-cell junction assembly | 3.789074e-3 |
GO:0006576 | cellular biogenic amine metabolic process | 3.907054e-3 |
GO:0071877 | regulation of adrenergic receptor signaling pathway | 3.946277e-3 |
GO:0001824 | blastocyst development | 4.027576e-3 |
GO:0008612 | peptidyl-lysine modification to hypusine | 4.028909e-3 |
GO:0060043 | regulation of cardiac muscle cell proliferation | 4.032199e-3 |
GO:0001505 | regulation of neurotransmitter levels | 4.045974e-3 |
GO:0003283 | atrial septum development | 4.055391e-3 |
GO:0003349 | epicardium-derived cardiac endothelial cell differentiation | 4.059217e-3 |
GO:0046532 | regulation of photoreceptor cell differentiation | 4.062768e-3 |
GO:0032446 | protein modification by small protein conjugation | 4.112849e-3 |
GO:0072070 | loop of Henle development | 4.116490e-3 |
GO:2000822 | regulation of behavioral fear response | 4.146415e-3 |
GO:0072171 | mesonephric tubule morphogenesis | 4.146415e-3 |
GO:0006809 | nitric oxide biosynthetic process | 4.146415e-3 |
GO:0071294 | cellular response to zinc ion | 4.203301e-3 |
GO:0015780 | nucleotide-sugar transport | 4.203301e-3 |
GO:0071107 | response to parathyroid hormone stimulus | 4.403104e-3 |
GO:0019368 | fatty acid elongation, unsaturated fatty acid | 4.403104e-3 |
GO:0043968 | histone H2A acetylation | 4.403104e-3 |
GO:0060821 | inactivation of X chromosome by DNA methylation | 4.476717e-3 |
GO:0060064 | Spemann organizer formation at the anterior end of the primitive streak | 4.476717e-3 |
GO:0060267 | positive regulation of respiratory burst | 4.600999e-3 |
GO:0060058 | positive regulation of apoptosis involved in mammary gland involution | 4.684236e-3 |
GO:0032469 | endoplasmic reticulum calcium ion homeostasis | 4.684287e-3 |
GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb | 4.684287e-3 |
GO:0009953 | dorsal/ventral pattern formation | 4.695480e-3 |
GO:0007521 | muscle cell fate determination | 4.765693e-3 |
GO:0000278 | mitotic cell cycle | 4.787178e-3 |
GO:0003139 | secondary heart field specification | 4.844679e-3 |
GO:0001886 | endothelial cell morphogenesis | 4.931022e-3 |
GO:0006868 | glutamine transport | 4.934745e-3 |
GO:0035633 | maintenance of blood-brain barrier | 5.073150e-3 |
GO:0090342 | regulation of cell aging | 5.094488e-3 |
GO:0070995 | NADPH oxidation | 5.196819e-3 |
GO:0072075 | metanephric mesenchyme development | 5.205579e-3 |
GO:0046015 | regulation of transcription by glucose | 5.206241e-3 |
GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 5.399438e-3 |
GO:0046839 | phospholipid dephosphorylation | 5.561619e-3 |
GO:0032026 | response to magnesium ion | 5.595595e-3 |
GO:0033239 | negative regulation of cellular amine metabolic process | 5.771507e-3 |
GO:0006270 | DNA-dependent DNA replication initiation | 5.771507e-3 |
GO:0034653 | retinoic acid catabolic process | 5.824503e-3 |
GO:0090161 | Golgi ribbon formation | 5.824503e-3 |
GO:0061050 | regulation of cell growth involved in cardiac muscle cell development | 5.824503e-3 |
GO:0043558 | regulation of translational initiation in response to stress | 5.824503e-3 |
GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process | 5.824503e-3 |
GO:0032509 | endosome transport via multivesicular body sorting pathway | 5.824503e-3 |
GO:0033683 | nucleotide-excision repair, DNA incision | 5.824503e-3 |
GO:0031400 | negative regulation of protein modification process | 5.957034e-3 |
GO:0070407 | oxidation-dependent protein catabolic process | 6.059758e-3 |
GO:0043000 | Golgi to plasma membrane CFTR protein transport | 6.059758e-3 |
GO:0009794 | regulation of mitotic cell cycle, embryonic | 6.059758e-3 |
GO:0007062 | sister chromatid cohesion | 6.158088e-3 |
GO:0090197 | positive regulation of chemokine secretion | 6.199705e-3 |
GO:0051891 | positive regulation of cardioblast differentiation | 6.254484e-3 |
GO:0021766 | hippocampus development | 6.283007e-3 |
GO:2001013 | epithelial cell proliferation involve in renal tubule morphogenesis | 6.320895e-3 |
GO:0070509 | calcium ion import | 6.320895e-3 |
GO:0072160 | nephron tubule epithelial cell differentiation | 6.320895e-3 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 6.382249e-3 |
GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change | 6.396799e-3 |
GO:0021526 | medial motor column neuron differentiation | 6.396799e-3 |
GO:0033523 | histone H2B ubiquitination | 6.486149e-3 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 6.488054e-3 |
GO:0090281 | negative regulation of calcium ion import | 6.488054e-3 |
GO:0070885 | negative regulation of calcineurin-NFAT signaling pathway | 6.488054e-3 |
GO:0071584 | negative regulation of zinc ion import | 6.488054e-3 |
GO:0034134 | toll-like receptor 2 signaling pathway | 6.488054e-3 |
GO:0051791 | medium-chain fatty acid metabolic process | 6.488054e-3 |
GO:0044314 | protein K27-linked ubiquitination | 6.488054e-3 |
GO:0048697 | positive regulation of collateral sprouting in absence of injury | 6.488054e-3 |
GO:0061056 | sclerotome development | 6.559696e-3 |
GO:0042402 | cellular biogenic amine catabolic process | 6.779541e-3 |
GO:0019276 | UDP-N-acetylgalactosamine metabolic process | 6.883507e-3 |
GO:0044240 | multicellular organismal lipid catabolic process | 6.947744e-3 |
GO:0019695 | choline metabolic process | 6.947744e-3 |
GO:0060523 | prostate epithelial cord elongation | 7.040700e-3 |
GO:0033137 | negative regulation of peptidyl-serine phosphorylation | 7.187910e-3 |
GO:0090403 | oxidative stress-induced premature senescence | 7.332968e-3 |
GO:0035907 | dorsal aorta development | 7.332968e-3 |
GO:0034770 | histone H4-K20 methylation | 7.332968e-3 |
GO:0048563 | post-embryonic organ morphogenesis | 7.342975e-3 |
GO:0070647 | protein modification by small protein conjugation or removal | 7.361366e-3 |
GO:0007008 | outer mitochondrial membrane organization | 7.404511e-3 |
GO:0003300 | cardiac muscle hypertrophy | 7.404511e-3 |
GO:0043506 | regulation of JUN kinase activity | 7.610361e-3 |
GO:0071542 | dopaminergic neuron differentiation | 7.711676e-3 |
GO:0035308 | negative regulation of protein dephosphorylation | 7.711676e-3 |
GO:0006730 | one-carbon metabolic process | 7.724122e-3 |
GO:0071108 | protein K48-linked deubiquitination | 7.749105e-3 |
GO:0000189 | MAPK import into nucleus | 7.930764e-3 |
GO:0046514 | ceramide catabolic process | 7.997392e-3 |
GO:0045936 | negative regulation of phosphate metabolic process | 8.041821e-3 |
GO:0060562 | epithelial tube morphogenesis | 8.160225e-3 |
GO:0060218 | hemopoietic stem cell differentiation | 8.171611e-3 |
GO:0031398 | positive regulation of protein ubiquitination | 8.247970e-3 |
GO:2000761 | positive regulation of N-terminal peptidyl-lysine acetylation | 8.386903e-3 |
GO:0035910 | ascending aorta morphogenesis | 8.386903e-3 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 8.386903e-3 |
GO:0000188 | inactivation of MAPK activity | 8.555026e-3 |
GO:0050891 | multicellular organismal water homeostasis | 8.589874e-3 |
GO:0007368 | determination of left/right symmetry | 8.689504e-3 |
GO:0007616 | long-term memory | 8.819543e-3 |
GO:0010921 | regulation of phosphatase activity | 8.878328e-3 |
GO:0061013 | regulation of mRNA catabolic process | 8.922978e-3 |
GO:0060061 | Spemann organizer formation | 8.956073e-3 |
GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway | 8.956073e-3 |
GO:0070585 | protein localization in mitochondrion | 9.048414e-3 |
GO:0071236 | cellular response to antibiotic | 9.055836e-3 |
GO:0019048 | virus-host interaction | 9.071208e-3 |
GO:0030299 | intestinal cholesterol absorption | 9.106056e-3 |
GO:0010694 | positive regulation of alkaline phosphatase activity | 9.199183e-3 |
GO:0043500 | muscle adaptation | 9.287714e-3 |
GO:0001844 | protein insertion into mitochondrial membrane involved in induction of apoptosis | 9.391054e-3 |
GO:0051597 | response to methylmercury | 9.605593e-3 |
GO:0072074 | kidney mesenchyme development | 9.605593e-3 |
GO:0021510 | spinal cord development | 9.626308e-3 |
GO:0072655 | establishment of protein localization in mitochondrion | 9.634049e-3 |
GO:0071482 | cellular response to light stimulus | 9.634049e-3 |
GO:0042743 | hydrogen peroxide metabolic process | 9.888909e-3 |
GO:0010332 | response to gamma radiation | 1.013864e-2 |
GO:0045040 | protein import into mitochondrial outer membrane | 1.027469e-2 |
GO:0031987 | locomotion involved in locomotory behavior | 1.027469e-2 |
GO:0006325 | chromatin organization | 1.034368e-2 |
GO:0033554 | cellular response to stress | 1.037135e-2 |
GO:0055098 | response to low-density lipoprotein particle stimulus | 1.051729e-2 |
GO:0019377 | glycolipid catabolic process | 1.051729e-2 |
GO:0001825 | blastocyst formation | 1.059118e-2 |
GO:0071498 | cellular response to fluid shear stress | 1.074087e-2 |
GO:0035909 | aorta morphogenesis | 1.103710e-2 |
GO:0003309 | type B pancreatic cell differentiation | 1.122831e-2 |
GO:0046902 | regulation of mitochondrial membrane permeability | 1.124198e-2 |
GO:0071277 | cellular response to calcium ion | 1.134222e-2 |
GO:0034405 | response to fluid shear stress | 1.137957e-2 |
GO:0006801 | superoxide metabolic process | 1.137957e-2 |
GO:0009084 | glutamine family amino acid biosynthetic process | 1.152653e-2 |
GO:0090196 | regulation of chemokine secretion | 1.153431e-2 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.154429e-2 |
GO:2000725 | regulation of cardiac muscle cell differentiation | 1.167387e-2 |
GO:0071599 | otic vesicle development | 1.167387e-2 |
GO:0060399 | positive regulation of growth hormone receptor signaling pathway | 1.167856e-2 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 1.175228e-2 |
GO:0032439 | endosome localization | 1.175228e-2 |
GO:0003026 | regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback | 1.175228e-2 |
GO:0035690 | cellular response to drug | 1.179058e-2 |
GO:0006479 | protein methylation | 1.181404e-2 |
GO:0071585 | detoxification of cadmium ion | 1.190034e-2 |
GO:0002355 | detection of tumor cell | 1.190034e-2 |
GO:0060763 | mammary duct terminal end bud growth | 1.211926e-2 |
GO:0060914 | heart formation | 1.213021e-2 |
GO:0009886 | post-embryonic morphogenesis | 1.216268e-2 |
GO:0021527 | spinal cord association neuron differentiation | 1.235483e-2 |
GO:0042363 | fat-soluble vitamin catabolic process | 1.246417e-2 |
GO:0032055 | negative regulation of translation in response to stress | 1.246417e-2 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 1.246417e-2 |
GO:0009799 | specification of symmetry | 1.246754e-2 |
GO:0016570 | histone modification | 1.248976e-2 |
GO:0009595 | detection of biotic stimulus | 1.249105e-2 |
GO:0032252 | secretory granule localization | 1.275984e-2 |
GO:0031124 | mRNA 3'-end processing | 1.294903e-2 |
GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 1.317460e-2 |
GO:0090136 | epithelial cell-cell adhesion | 1.322714e-2 |
GO:0050853 | B cell receptor signaling pathway | 1.323320e-2 |
GO:0007006 | mitochondrial membrane organization | 1.330522e-2 |
GO:0060485 | mesenchyme development | 1.343728e-2 |
GO:0007493 | endodermal cell fate determination | 1.345302e-2 |
GO:0010614 | negative regulation of cardiac muscle hypertrophy | 1.345302e-2 |
GO:0006699 | bile acid biosynthetic process | 1.345302e-2 |
GO:0046496 | nicotinamide nucleotide metabolic process | 1.348110e-2 |
GO:0031058 | positive regulation of histone modification | 1.355703e-2 |
GO:0034372 | very-low-density lipoprotein particle remodeling | 1.358258e-2 |
GO:0031571 | mitotic cell cycle G1/S transition DNA damage checkpoint | 1.382342e-2 |
GO:0060992 | response to fungicide | 1.384510e-2 |
GO:0045216 | cell-cell junction organization | 1.386270e-2 |
GO:0046826 | negative regulation of protein export from nucleus | 1.414483e-2 |
GO:0033299 | secretion of lysosomal enzymes | 1.422899e-2 |
GO:0006542 | glutamine biosynthetic process | 1.422899e-2 |
GO:0045824 | negative regulation of innate immune response | 1.472699e-2 |
GO:0001829 | trophectodermal cell differentiation | 1.502593e-2 |